Fuller H B price to free cash flow FUL
Market value divided by free cash flow over the last twelve months, since 2011.
- Today, Oct 23, 2026
- 26.7×
- 10-year median
- 18.9×
- Against its 10-year history
- 71st
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 5.9× to 378×
- Peer median
- 24.8×
Fuller H B's price to free cash flow is 26.7× as of Oct 23, 2026.
That is above its ten-year median of 18.9×, higher than on 71% of days in the last ten years.
Over that time it ranged from 5.9× in Apr 2020 to 378× in Aug 2022.
The median for 10 chemicals stocks of a similar size is 24.8×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 26.7× | 18.9× | 30.2× |
| 2025 | 27.1× | 13.1× | 42.2× |
| 2024 | 14.4× | 13.2× | 17.2× |
| 2023 | 15.5× | 12.4× | 31.4× |
| 2022 | 320× | 18.4× | 378× |
| 2021 | 20.6× | 10.8× | 20.6× |
| 2020 | 12.5× | 5.9× | 12.9× |
| 2019 | 11.1× | 8.5× | 21.3× |
| 2018 | 19.5× | 18.4× | 71.6× |
| 2017 | 38.0× | 16.9× | 41.0× |
| 2016 | 16.9× | 11.8× | 20.1× |
| 2015 | 21.3× | 21.1× | 24.7× |
| 2014 | 287× | 74.4× | 290× |
| 2013 | 80.1× | 23.7× | 80.1× |
| 2012 | 22.5× | 15.8× | 24.6× |
| 2011 | 15.4× | 12.1× | 21.5× |
Against its peers
Companies in Chemicals nearest Fuller H B's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| FULFuller H B | 26.7× |
| WDFCWD 40 | 35.9× |
| IOSPInnospec | 34.7× |
| NGVTIngevity | 15.5× |
| ROGRogers | 27.0× |
| AVNTAvient | 19.7× |
| CBTCabot | 13.6× |
| CSWCSW Industrials | 33.4× |
| BCPCBalchem | n/m |
| CRONCronos | 24.8× |
| HXLHexcel | 23.6× |
| Peer median | 24.8× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Fuller H B
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.